Genpact Ltd Dossier - Source-backed chat

Genpact Ltd

GNYSE

SectorInformation Technology

IndustryInformation Technology Services

Beta (adjusted)0.73

Intrinsic Value $61.69median of 6 methods · middle span $47-$163based on filings through 30 Jun 2026

Market Price $34.70Price as of 1 Oct 2026

Significantly undervaluedIntrinsic value is 78% above the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

marker beyond scale (+78%)

Data confidence Sign in to view data confidence

Market Cap $5.8B

Enterprise Value $6.5B

Shares Outstanding 170.5M diluted

Moat Rating Wide

Next Earnings Date5 Nov 2026

Last ex-dividend10 Sep 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Genpact is successfully executing its strategic pivot toward high-value, AI-driven Advanced Technology Solutions (ATS), which grew 24.3% YoY in Q1 2026 and now represents 27% of total revenues. This shift is driving gross margin expansion and robust bottom-line performance, as evidenced by a strong Q1 2026 adjusted EPS beat of $0.98. However, the broader IT services and consulting sector faces severe headwinds in 2026 due to macroeconomic caution, client spending constraints, and persistent fears that generative AI automation could cannibalize legacy headcount-based business process outsourcing (BPO) models. While Genpact's valuation is highly compressed (trading at a single-digit trailing P/E of ~9.3x), near-term stock momentum remains weak, down over 33% YTD. A Hold rating is maintained as the market weighs the rapid growth of its agentic AI offerings against the stagnation of its legacy Core Business Services.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets11 analysts · as of 18 Aug 2026

Low · most bearish analyst$31.00

Mean target$42.18

High · most bullish analyst$58.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$31.00

Persistent client spending delays and rapid AI-driven automation cannibalize legacy BPO contracts faster than ATS can scale. Intense competition from consulting giants and offshore IT players pressures pricing, leading to margin compression and a failure to meet the 7% full-year revenue growth target.

Base CaseCentral scenario

$42.18

Matches the consensus mean

Genpact continues its steady execution, with ATS growing at least 20% and total revenue growing by ~7% in FY2026. Legacy Core Business Services remain flat to slightly positive, providing stable cash flows. Operating margins remain stable around 17.3% to 17.5%, and the stock slowly recovers toward its historical average multiples as AI cannibalization fears prove overblown.

Bull CaseUpside scenario

$58.00

Genpact's 'GenpactNext' strategy accelerates, with agentic AI and ATS solutions scaling faster than expected to offset legacy BPO declines. The company successfully transitions to non-FTE, outcome-based pricing models, driving adjusted operating margins toward 18% and triggering a significant valuation re-rating as the market recognizes it as an AI beneficiary rather than a victim.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Accelerating momentum in Advanced Technology Solutions (ATS), which grew 24.3% YoY in Q1 2026, driven by strong enterprise demand for agentic AI and digital transformation.
Consistent operational discipline leading to 12 consecutive quarters of year-over-year gross margin expansion, reaching 36.4% in Q1 2026.
Highly attractive valuation with a trailing P/E of ~9.3x and a robust free cash flow yield, supported by a disciplined capital allocation strategy including active share buybacks and a stable dividend yield of ~2.4%.

Key Investment Risks

Macroeconomic headwinds and cautious enterprise IT spending leading to slower decision-making cycles and smaller transformation deal sizes.
Long-term risk of generative AI automating and cannibalizing traditional headcount-based (FTE) business process outsourcing services, which still represent 73% of revenues.
Intense competition from both global technology consulting giants (e.g., Accenture) and offshore IT service providers, limiting pricing power.

Thesis Invalidation Triggers

Advanced Technology Solutions (ATS) revenue growth slowing to below 15% YoY, indicating a loss of market share or a slowdown in enterprise AI adoption.
Adjusted operating margins falling below 16.5% due to pricing pressure or wage inflation.
A material contraction in legacy Core Business Services revenue (greater than 3% decline YoY) that outpaces the growth of digital services.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.